BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Curpan AS, Luca AC, Ciobica A. Potential Novel Therapies for Neurodevelopmental Diseases Targeting Oxidative Stress. Oxid Med Cell Longev 2021;2021:6640206. [PMID: 34336109 DOI: 10.1155/2021/6640206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lai CC, Baskaran R, Tsao CY, Tuan LH, Siow PF, Palani M, Lee LJ, Liu CM, Hwu HG, Lee LJ. Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced Hyperactivity in Heterozygous Disc1 Mutant Mice, a Putative Prodromal Schizophrenia Animal Model. Int J Mol Sci 2022;23:9419. [PMID: 36012679 DOI: 10.3390/ijms23169419] [Reference Citation Analysis]
2 Zavadenko N, Suvorinova N, Batysheva T, Bykova O, Platonova A, Gaynetdinova D, Levitina E, Mashin V, Vakula I, Maximova N. Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA). Z nevrol psikhiatr im S S Korsakova 2022;122:75. [DOI: 10.17116/jnevro202212204175] [Cited by in F6Publishing: 1] [Reference Citation Analysis]